Directory of sitesLoginContactSupport
for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Meridian Bioscience, Inc.

VIVO.OQ

Latest Trade

23.93USD

Change

-1.02(-4.09百分比)

Volume

174,609

Today's Range

23.78

?-?

25.15

52 Week Range

5.51

?-?

25.25

As of on the NASDAQ ? Minimum 15 minute delay

Pricing

Previous Close
24.95
Open
24.96
Volume
174,609
3M AVG Volume
19.15
Today's High
25.15
Today's Low
23.78
52 Week High
25.25
52 Week Low
5.51
Shares Out (MIL)
42.83
Market Cap (MIL)
1,024.99
Forward P/E
31.28
Dividend (Yield 百分比)
--

Latest Developments

更好优质

Meridian Bioscience Reports Second Quarter 2020 Operating Results Raises Guidance On Strength Of Covid-19 Related Products

Meridian Bioscience Announces Preliminary Q2 2020 Revenue Results

Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results And Reaffirms 2020 Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Meridian Bioscience, Inc.

Meridian Bioscience, Inc. is a life science company engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, viral, respiratory and parasitic infectious diseases, and elevated blood lead levels, and the manufacture and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, competent cells and bioresearch reagents used by researchers and other diagnostic manufacturers. Its segments include Diagnostics and Life Science. The Diagnostics segment includes manufacturing operations in Cincinnati, and the sale and distribution of diagnostic test kits in the countries consisting of North, Central and South America; Europe, the Middle East and Africa (EMEA), and other countries outside of the Americas and EMEA. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; Luckenwalde, Germany, and Sydney, Australia.

Industry

Medical Equipment & Supplies

Contact Info

3471 River Hills Dr

CINCINNATI, OH

45244

United States

+1.513.2713700

http://www.meridianbioscience.com

Executive Leadership

David C. Phillips

Independent Chairman of the Board

John P. Kenny

Chief Executive Officer, Director

Bryan T. Baldasare

Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller, Treasurer

Lourdes Weltzien

Executive Vice President - Life Science

James M. Anderson

Independent Director

Key Stats

1.00 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

0.2K

2018

0.2K

2019

0.2K

2020(E)

0.2K
EPS (USD)

2017

0.670

2018

0.740

2019

0.680

2020(E)

0.765
Price To Earnings (TTM)
48.08
Price To Sales (TTM)
5.02
Price To Book (MRQ)
5.01
Price To Cash Flow (TTM)
31.06
Total Debt To Equity (MRQ)
23.87
LT Debt To Equity (MRQ)
23.87
Return on Investment (TTM)
8.36
Return on Equity (TTM)
7.46

Latest News

Latest News

UPDATE 1-FDA approves Meridian Bioscience's test for herpes in newborns

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

FDA approves Meridian Bioscience's diagnostic for herpes in newborns

The U.S. Food and Drug Administration approved on Friday a diagnostic test from Meridian Bioscience Inc as the first tool to help detect a type of herpes virus in newborns.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
XML 地图 | Sitemap 地图